Phreesia/$PHR

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Phreesia

Phreesia Inc is a provider of comprehensive software solutions that improve the operational and financial performance of healthcare organizations by activating patients in their care to optimize patient health outcomes. Through its SaaS-based technology platform, it offers healthcare services clients a robust suite of integrated solutions that manage patient access, registration, payments, and clinical support. The Phreesia Platform encompasses a comprehensive range of technologies and services, including, initial patient contact, registration, automated answering services, appointment scheduling, payments, and post-appointment patient surveys.

Ticker

$PHR
Sector

Primary listing

NYSE

Employees

2,082

Phreesia Metrics

BasicAdvanced
$1.4B
-
-$0.42
0.68
-

What the Analysts think about Phreesia

Analyst ratings (Buy, Hold, Sell) for Phreesia stock.

Bulls say / Bears say

Phreesia posted its first-ever GAAP net income-positive quarter in Q2 FY2026, reporting net income of $0.7 million versus a net loss of $18.0 million a year ago, demonstrating clear progress toward profitability (Business Wire)
Revenue was up 15% year-over-year at $117.3 million in Q2 FY2026, with strong double-digit growth across subscription services, network solutions, and payment processing fees (Business Wire)
The $160 million all-cash purchase of AccessOne is expected to add around $35 million in annualized revenue and $11 million in Adjusted EBITDA, broadening Phreesia’s addressable market for payment solutions by roughly $6 billion (HLTH.com)
Sequential client growth slowed in Q2, with Phreesia adding only 56 net new healthcare services clients compared to 70 in the previous quarter, suggesting potential market saturation in its core area (Nasdaq)
Management kept full-year 2026 revenue guidance unchanged at $472 million–$482 million despite a strong Q2, signaling that they don't expect significant short-term upside to revenue forecasts (Nasdaq)
Phreesia shares declined 8.8% after announcing Q2 earnings and the AccessOne acquisition, pointing to investor worries about the debt-financed deal and possible distraction from its main business (Investing.com)
Data summarised monthly by Lightyear AI. Last updated on 3 Oct 2025.

Phreesia Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Phreesia Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $PHR

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs
Buy Phreesia stock | $PHR Share Price | Lightyear